Furthermore, 1-MNAM demonstrated superior capability in distinguishing HCC from the high-risk population (cirrhosis) compared to traditional blood markers (such as AFP, CA19-9, and CA125). This evidence concerns the gene AFP and hepatocellular carcinoma.